NDC 0409-7299

Sodium Acetate

Sodium Acetate

Sodium Acetate is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Sodium Acetate Anhydrous.

• Product ID: 0409-7299_1bfbf05c-854b-4a04-bb2b-460c75e045fb
• NDC: 0409-7299
• Product Type: Human Prescription Drug
• Proprietary Name: Sodium Acetate
• Generic Name: Sodium Acetate
• Dosage Form: Injection, Solution, Concentrate
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2014-03-05
• Marketing Category: NDA / NDA
• Application Number: NDA018893
• Labeler Name: Hospira, Inc.
• Substance Name: SODIUM ACETATE ANHYDROUS
• Active Ingredient Strength: 3 g/20mL
• Pharm Classes: Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 0409-7299-25

25 VIAL, SINGLE-DOSE in 1 TRAY (0409-7299-25) > 20 mL in 1 VIAL, SINGLE-DOSE (0409-7299-45)

• Marketing Start Date: 2014-03-05
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0409-7299-73 [00409729973]

Sodium Acetate INJECTION, SOLUTION, CONCENTRATE

• Marketing Category: NDA
• Application Number: NDA018893
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2005-03-31

NDC 0409-7299-45 [00409729945]

Sodium Acetate INJECTION, SOLUTION, CONCENTRATE

• Marketing Category: NDA
• Application Number: NDA018893
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2017-12-05

NDC 0409-7299-25 [00409729925]

Sodium Acetate INJECTION, SOLUTION, CONCENTRATE

• Marketing Category: NDA
• Application Number: NDA018893
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2014-03-05

NDC 0409-7299-83 [00409729983]

Sodium Acetate INJECTION, SOLUTION, CONCENTRATE

• Marketing Category: NDA
• Application Number: NDA018893
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2017-04-06

Drug Details

Active Ingredients

Ingredient	Strength
SODIUM ACETATE ANHYDROUS	3.28 g/20mL

OpenFDA Data

• SPL SET ID: ce9a7469-c4ba-4f60-8f7a-47ef0974316e
• Manufacturer:
  • Hospira, Inc.
• UNII:
  • NVG71ZZ7P0
• RxNorm Concept Unique ID - RxCUI:
  • 1859490

Pharmacological Class

• Osmotic Laxative [EPC]
• Increased Large Intestinal Motility [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Osmotic Activity [MoA]

NDC Crossover Matching brand name "Sodium Acetate" or generic name "Sodium Acetate"

NDC	Brand Name	Generic Name
0409-3299	Sodium Acetate	sodium acetate
0409-7299	Sodium Acetate	SODIUM ACETATE
51754-9995	Sodium Acetate	Sodium Acetate
63323-032	SODIUM ACETATE	SODIUM ACETATE
69784-230	SODIUM ACETATE	SODIUM ACETATE
69784-231	SODIUM ACETATE	SODIUM ACETATE
0517-5023	Sodum Acetate	Sodium Acetate